Endothelial metabolism of L-arginine to L-citrulline and the potent vasodilator, nitric oxide (NO) 
mals produces acute hypertension1,2 and long-term NOS inhibition leads to chronic systemic hyperten¬ sion.4 As well, endothelium-dependent vasodilation has been found to be impaired in essential hyperten¬ sion in humans, suggesting that endothelial dysfunc¬ tion and inadequate NO production may be important in the pathogenesis of this disorder. 5, 6 The parenteral administration of L-arginine re¬ verses the acute hypertensive effect of NOS inhibition in animals1'7 and has an acute hypotensive effect in humans.8,9 These hemodynamic effects have been presumed to be the result of increased L-arginine metabolism by endothelial NOS (eNOS) and increased NO production. Recently, several groups have used a very sensitive chemiluminescence technique to mea¬ sure extremely low, physiologic levels of NO in the parts per billion (ppb) range in the expired gas of an¬ imals and humans.10,11 Thus, we hypothesized that if the hemodynamic effects of L-arginine were mediated by increased endogenous NO production, this should be reflected by an increase in expired NO. The specific aim of the present study was to determine the effect of L-arginine infusion on expired NO in humans and to relate changes in pulmonary NO excretion to the hemodynamic and metabolic effects of L-arginine.
Materials and Methods

Study Population
Ten healthy, nonsmoking, white men (34±2 years; mean±SEM) were studied. Three subjects with a smokinghistory (total exposure, 5 to 10 pack years) had stopped smoking at least 1 year before the study. None 
Hemodynamic Effects of L-Arginine
Infusion of exogenous L-arginine reduced systolic, mean, and diastolic BP in all subjects with a peak ef¬ fect on mean BP of -9.3±0.9% (p<0.005) at 32±7 min after start of the L-arginine infusion (Fig 1) . (Fig  1) , although in two individuals, expired NO changed markedly in opposing directions (Fig 2) . Minute ven¬ tilation also increased by 28±10% from 10 
